Related Experiment Videos
Semipermeability imparted by surface-active phospholipid in peritoneal dialysis.
Yi Chen1, John R Burke, Brian A Hills
1Paediatric Respiratory Research Centre, Mater Children's Hospital, Brisbane, Queensland, Australia.
Summary
Surface-active phospholipid (SAPL) lining on peritoneal mesothelium imparts semipermeability, crucial for ultrafiltration (UF) in peritoneal dialysis (PD). Synthetic SAPL shows potential for restoring UF in PD patients.
Area of Science:
- Biomedical Engineering
- Physiology
- Materials Science
Background:
- Surface-active phospholipid (SAPL) adsorbs to peritoneal mesothelium, acting as a lubricant and anti-stick agent.
- SAPL's role in maintaining mechanical integrity and potentially imparting semipermeability for ultrafiltration (UF) in peritoneal dialysis (PD) is hypothesized.
Purpose of the Study:
- To evaluate the hypothesis that SAPL lining imparts semipermeability vital for UF in PD.
- To investigate the osmotic properties of human peritoneal SAPL and synthetic SAPL formulations.
Main Methods:
- SAPL harvested from PD patients' spent dialysate was deposited onto an inert medium.
- These "membranes" were tested in an Ussing chamber as an osmometer with glucose solutions against saline.
Main Results:
- Human peritoneal SAPL demonstrated the ability to induce significant osmotic pressure with a clinical glucose concentration.
- Synthetic SAPL, including dipalmitoyl phosphatidylcholine (DPPC) and artificial lung-expanding compound (ALEC), showed increased osmotic pressure with higher glucose gradients.
Conclusions:
- Adsorbed SAPL has the physical capability to impart semipermeability, potentially explaining UF in PD.
- ALEC and DPPC, known for their safety in treating respiratory distress syndrome, offer potential for restoring UF in PD patients.
- Formulation of exogenous SAPL for UF restoration involves balancing surface activity and solubility.